治疗延迟对伴或不伴血流动力学不稳定的STEMI患者死亡率的影响:德国FITT-STEMI试验结果
结果显示在60至180分钟治疗窗内,各亚组均呈近线性关系;心源性休克无院外心脏骤停患者每延迟10分钟,每100例PCI治疗患者增加3.31例死亡,显著高于其他亚组。结论提示心源性休克患者从立即PCI获益最大,应特别努力缩短其接触至球囊时间。
要点
- 心源性休克无OHCA的STEMI患者每延迟10分钟PCI,每100例增加3.31例死亡。
- 该延迟相关死亡率增加显著高于OHCA伴休克(2.09)、OHCA无休克(1.34)及血流动力学稳定患者(0.34)。
- 心源性休克STEMI患者从立即PCI获益最大,应优先缩短接触至球囊时间。
核心结论
- 在心源性休克STEMI患者中,首次医疗接触至直接PCI的时间是不良结局的强预测因子。
- 该组患者从立即PCI治疗中获益最大,应特别努力缩短其接触至球囊时间。
研究设计与样本
- 德国前瞻性、多中心FITT-STEMI试验(NCT00794001)。
- 按心源性休克和院外心脏骤停进行分层分析。
主要发现
- 在首次医疗接触后60至180分钟内治疗的患者中,四个STEMI亚组的接触至球囊时间与死亡率均呈近线性关系。
- 心源性休克无OHCA患者每延迟10分钟,每100例PCI治疗患者增加3.31例死亡。
- OHCA伴休克患者每延迟10分钟每100例增加2.09例死亡,OHCA无休克患者增加1.34例,血流动力学稳定患者增加0.34例(P < 0.0001)。
临床怎么用
- 对心源性休克STEMI患者应特别优化急救流程,缩短首次医疗接触至球囊扩张时间。
- 将心源性休克无OHCA患者作为时间依赖性死亡率最高的高危群体优先干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this study was to investigate the effect of contact-to-balloon time on mortality in ST-segment elevation myocardial infarction (STEMI) patients with and without haemodynamic instability. METHODS AND RESULTS: Using data from the prospective, multicentre Feedback Intervention and Treatment Times in ST-Elevation Myocardial Infarction (FITT-STEMI) trial, we assessed the prognostic relevance of first medical contact-to-balloon time in n = 12 675 STEMI patients who used emergency medical service transportation and were treated with primary percutaneous coronary intervention (PCI). Patients were stratified by cardiogenic shock (CS) and out-of-hospital cardiac arrest (OHCA). For patients treated within 60 to 180 min from the first medical contact, we found a nearly linear relationship between contact-to-balloon times and mortality in all four STEMI groups. In CS patients with no OHCA, every 10-min treatment delay resulted in 3.31 additional deaths in 100 PCI-treated patients. This treatment delay-related increase in mortality was significantly higher as compared to the two groups of OHCA patients with shock (2.09) and without shock (1.34), as well as to haemodynamically stable patients (0.34, P < 0.0001). CONCLUSIONS: In patients with CS, the time elapsing from the first medical contact to primary PCI is a strong predictor of an adverse outcome. This patient group benefitted most from immediate PCI treatment, hence special efforts to shorten contact-to-balloon time should be applied in particular to these high-risk STEMI patients. CLINICAL TRIAL REGISTRATION: NCT00794001.
引用
- Scholz KH, Maier SKG, Maier LS, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018. PMID: 29452351. doi:10.1093/eurheartj/ehy004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。